April Huang
About April Huang
April Huang is the Director of SSU and Clinical Monitoring at BeiGene in Beijing, China, with over 20 years of experience in clinical research and project management, having held leadership roles at GSK, Bayer, and Novartis.
Title
April Huang serves as the Director of SSU and Clinical Monitoring at BeiGene in Peking, Beijing, China. She is responsible for overseeing the clinical monitoring and study start-up processes.
Current Role at BeiGene
April Huang is currently employed at BeiGene as the Director of SSU and Clinical Monitoring. Her responsibilities include overseeing the establishment and monitoring of clinical trials, ensuring compliance with regulatory requirements, and optimizing study start-up procedures. She brings extensive experience and specialized expertise to her role in one of China's most prominent biotechnology companies.
Previous Experience at GSK
April Huang has held significant roles at GSK. From 2016 to 2018, she served as the Operation Science Leader. Prior to that, she worked as a Senior Clinical Research Associate (CRA) from 2008 to 2010. In these capacities, she gained valuable experience in clinical research operations and project leadership.
Global Study Manager at Bayer
From 2012 to 2016, April Huang worked at Bayer as a Global Study Manager. During her tenure, she was responsible for managing global clinical studies, coordinating with various departments, and ensuring the successful execution of clinical trials. Her role at Bayer solidified her expertise in global project management.
Education and Expertise
April Huang holds a Master of Business Administration from Guanghua School of Management, Peking University, completed between 2017 and 2019. She also achieved a Bachelor's degree from Beijing University of Chinese Traditional Medicine, where she studied from 1995 to 2000. Her educational background provides her with a strong foundation in both traditional Chinese medicine and modern pharmaceutical practices, enhancing her comprehensive understanding of the clinical research field.